Staidson (300204.SZ) announcement, the company received the approval from the National Medical Products Administration in July 2024...
Zhitong Finance APP news, Staidson (300204.SZ) announcement, in July 2024, the company received the "Drug Clinical Trial Approval Notice" for STSP-0902 eye drops to treat neurotrophic keratitis, allowing the drug to conduct clinical trials for neurotrophic keratitis. Recently, the first subject in Phase I clinical trial for neurotrophic keratitis was dosed with STSP-0902 eye drops at Peking Union Medical College Hospital affiliated to Peking University Hospital.